Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.938
-0.036 (-3.74%)
Jan 22, 2025, 4:00 PM EST - Market closed
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $70.33 million as of January 22, 2025. Its market cap has increased by 252.41% in one year.
Market Cap
70.33M
Enterprise Value
-11.80M
1-Year Change
252.41%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $70.33M, an increase of 37.83%. That is a compound annual growth rate of 10.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 73.06M | -7.22% |
| Dec 31, 2024 | 78.75M | 336.48% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.44B |
| UnitedHealth Group | 483.14B |
| Johnson & Johnson | 356.69B |
| Novo Nordisk | 355.54B |
| AbbVie | 305.03B |
| Merck & Co. | 243.45B |
| Thermo Fisher Scientific | 219.20B |
| Intuitive Surgical | 215.18B |